Field Clinical Specialist
Boost your chances before you apply.
BiVACOR Inc
Huntington Beach, CA, US
Summary
Provide specialized clinical nursing support and education for patients receiving advanced mechanical circulatory support. Train nursing staff at implanting centers and collaborate with engineering teams to develop patient management protocols.
Job Description
Help Us Build the Future of the Human Heart.
At BiVACOR, we’re developing the world’s most advanced total artificial heart, a technology capable of saving millions of lives around the world. We’re a team united by purpose, working on something truly unprecedented. Every role you take on, every patient you support, and every challenge you overcome plays a direct role in giving patients another shot at life. If that’s the kind of work that gets you out of bed in the morning, we think you belong here.
About the Role
This is a high-impact, patient-facing clinical role in a Class III medical device environment, where your expertise will directly support patients receiving the world’s most advanced mechanical circulatory support. As a Field Clinical Specialist, you will be the frontline clinical resource at implanting centers, bridging nursing practice, patient education, and cutting-edge MCS technology to help move us closer to transforming the lives of patients with end-stage heart failure.
Key Responsibilities
-
Provide specialized clinical nursing support for patients receiving mechanical circulatory support
-
Deliver patient and family education on device management, alarm response, and discharge protocols
-
Train nursing staff at implanting centers in MCS patient care competencies
-
Collaborate with clinical and engineering teams to develop and review patient management protocols
-
Participate in patient assessment and post-operative follow-up in conjunction with the medical team
-
Support the development of nursing-focused educational content for the LMS platform
What You Bring
-
Registered Nurse with current licensure; Bachelor of Nursing or equivalent degree preferred
-
Minimum 3–5 years of experience in cardiac surgery, cardiology, or critical care nursing
-
Prior exposure to mechanical circulatory support (VAD, ECMO, or TAH) strongly preferred
-
Demonstrated ability to develop and deliver clinical education programs for multidisciplinary audiences
-
Strong communication skills with the ability to translate complex clinical concepts for patients, families, and staff
-
Can-do attitude — big-picture thinking — strong teamwork and communication
-
Willingness to travel regularly to implanting center sites; flexibility for on-call clinical support
-
Experience with LMS platforms or digital learning content development is an advantage
What We Offer
BiVACOR offers a competitive compensation package and comprehensive benefits, including:
-
401(k) with company matching
-
Medical, dental, and vision insurance
-
Health Savings Account (HSA) & Flexible Spending Account (FSA)
-
Life insurance & Employee Assistance Program
-
Generous paid time off
This is a field-based role with regular travel to implanting centers across the US and internationally. The expected salary range for this position is $130,000 to $155,000 annually. Actual compensation will be determined based on experience, qualifications, geographic location, and other job-related factors permitted by law. A discretionary annual bonus may be available based on individual and Company performance. This position also qualifies for the benefits detailed at the link provided below. Relocation benefits are not available for this posting.
Apply today and be part of something extraordinary.
BiVACOR is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.
BiVACOR® is a clinical-stage medical device company pioneering the development of a long-term therapy for patients with biventricular heart failure. Under the expert direction of its founder and Total Artificial Heart (TAH) inventor, Daniel Timms, PhD, and the guidance of two luminaries in cardiovascular surgery, William E. Cohn, MD, and O.H. (Bud) Frazier, MD, the BiVACOR TAH is currently undergoing an FDA-approved first-in-human Early Feasibility Study (EFS). Headquartered in Huntington Beach, California, with clinical offices in Houston, Texas, and international offices in Gold Coast, Australia, BiVACOR is committed to addressing the global unmet need of patients with end-stage heart failure awaiting transplant by providing the next generation of life-extending solutions.
About the BiVACOR Total Artificial Heart (TAH):
The BiVACOR TAH represents a paradigm shift in artificial heart design. The size of the BiVACOR TAH is suitable for most men and women (Body Surface Area >1.4 m2). Despite its small size, the BiVACOR TAH is capable of providing enough cardiac output for an adult male undergoing exercise. Using magnetic levitation technology, the same principle used in high-speed trains, the product features a unique pump design with a single moving part: a magnetically suspended dual-sided rotor with left and right vanes positioned within two separate pump chambers, forming a double-sided centrifugal impeller that propels blood from the respective pump chambers to the pulmonary (lung) and systemic (body) circulations. The TAH has no valves or flexing ventricle chambers, with MAGLEV making pulsatile outflow possible by rapidly cycling the pump's rotor. The non-contact suspension of the rotor via MAGLEV is designed to eliminate the potential for mechanical wear and provide large blood gaps that minimize blood trauma, offering a durable, reliable, and biocompatible heart replacement.
Founded
2008
Company size
11-50 employees
Industry
Medical Equipment Manufacturing
Org type
Privately Held
Headquarters
Huntington Beach, California
BiVACOR® is a clinical-stage medical device company pioneering the development of a long-term therapy for patients with biventricular heart failure. Under the expert direction of its founder and Total Artificial Heart (TAH) inventor, Daniel Timms, PhD, and the guidance of two luminaries in cardiovascular surgery, William E. Cohn, MD, and O.H. (Bud) Frazier, MD, the BiVACOR TAH is currently undergoing an FDA-approved first-in-human Early Feasibility Study (EFS). Headquartered in Huntington Beach, California, with clinical offices in Houston, Texas, and international offices in Gold Coast, Australia, BiVACOR is committed to addressing the global unmet need of patients with end-stage heart failure awaiting transplant by providing the next generation of life-extending solutions.
About the BiVACOR Total Artificial Heart (TAH):
The BiVACOR TAH represents a paradigm shift in artificial heart design. The size of the BiVACOR TAH is suitable for most men and women (Body Surface Area >1.4 m2). Despite its small size, the BiVACOR TAH is capable of providing enough cardiac output for an adult male undergoing exercise. Using magnetic levitation technology, the same principle used in high-speed trains, the product features a unique pump design with a single moving part: a magnetically suspended dual-sided rotor with left and right vanes positioned within two separate pump chambers, forming a double-sided centrifugal impeller that propels blood from the respective pump chambers to the pulmonary (lung) and systemic (body) circulations. The TAH has no valves or flexing ventricle chambers, with MAGLEV making pulsatile outflow possible by rapidly cycling the pump's rotor. The non-contact suspension of the rotor via MAGLEV is designed to eliminate the potential for mechanical wear and provide large blood gaps that minimize blood trauma, offering a durable, reliable, and biocompatible heart replacement.
Founded
2008
Company size
11-50 employees
Industry
Medical Equipment Manufacturing
Org type
Privately Held
Headquarters
Huntington Beach, California